Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, Phase 3 Study of OTO-201 Given as a Single Administration for Treatment of Acute Otitis Externa

NCT02801370 is registered in ClinicalTrials.gov with Otonomy, Inc. as lead sponsor.

NCT NCT02801370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02801370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, Phase 3 Study of OTO-201 Given as a Single Administration for Treatment of Acute Otitis Externa
Lead sponsor
Otonomy, Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2016
Completion date
December 31, 2016
Enrollment
262 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute otitis externa, swimmer's ear